Retension Pharmaceuticals, Inc. RTSN

IPO NASDAQ
IPO Score
IPO Date
Oct 08, 2026
Recommendation
Dividend Power Score
Day's Range
$12.70$14.60
Latest Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Corporate Info
Phone Number
(703) 940-9761
Address
1104 West Broad Street #1029
Falls Church, VA 22046
Country
United States
Year Founded
2023
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
12
Business Description
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.